logo
Plus   Neg
Share
Email

Allergan Shareholders Oks Acquisition By AbbVie

Allergan plc (AGN) said Monday that a majority of its shareholders approved the proposed acquisition of Allergan by AbbVie Inc (ABBV).

Allergan stated that more than 99 percent of the votes cast at both a special court-ordered meeting of shareholders and at an extraordinary general meeting of shareholders were in favor of the transaction, representing about 68.6 percent of the shares outstanding and eligible to be voted at each of the Allergan shareholder meetings.

In June 2019, AbbVie agreed to acquire Allergan in a cash and stock transaction with an equity value of approximately $63 billion. The transaction is expected to close in early 2020, subject to customary closing conditions and regulatory approvals.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. has invested $394 million in U.S. electric air-taxi startup Joby Aviation as lead investor in the recent $590 million Series C financing. Toyota said it is continuing to leverage emerging technologies to provide "Mobility for All" as the lead investor as part of its transformation into a mobility company. As the world is facing severe consequences of increasing carbon emissions, Microsoft has announced various plans to tackle the issue. The company aims to reduce its own carbon emissions by more than half, and to be carbon negative by 2030. This means the company will remove more carbon than it emits each year. The company further announced a new $1 billion Climate Innovation Fund. With a view to expanding its presence in France, where it has been doing business for more than 100 years, Food and beverage giant Coca-Cola Co. (KO), during the Choose France Summit, announced 1 billion euros of investments in the country over the next five years. Coca-Cola Chairman and CEO James Quincey and President Emmanuel Macron is scheduled to elaborate on the plans in September.
Follow RTT
>